Blood Sampling Study for Sickle Cell Disease Research Initiated by NIDDK
A study has been launched to collect blood samples from individuals with unique red blood cell features related to sickle cell disease.
Indication
Clinical and regulatory intelligence for Sickle Cell Disease with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
A clinical trial is underway to evaluate the efficacy of VAS-101, a skin gel containing curcumin, in patients with stable sickle cell disease.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.